CS
BIOA

Credit Suisse’s BioAmber Inc. BIOA Stock Holding History

Credit Suisse’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,849
Closed -$123K – 4431
2015
Q4 		$123K Sell
19,849
-3,122
-14% -$23.5K ﹤0.01% 4046
2015
Q3 		$123K Sell
22,971
-20,538
-47% -$136K ﹤0.01% 4071
2015
Q2 		$374K Sell
43,509
-7,937
-15% -$72.6K ﹤0.01% 3899
2015
Q1 		$448K Buy
51,446
+31
+0.1% +$272 ﹤0.01% 3620
2014
Q4 		$431K Sell
51,415
-3,584
-7% -$32.6K ﹤0.01% 3813
2014
Q3 		$549K Buy
54,999
+44,166
+408% +$517K ﹤0.01% 3577
2014
Q2 		$108K Sell
10,833
-9,183
-46% -$94.8K ﹤0.01% 4524
2014
Q1 		$229K Buy
20,016
+7,759
+63% +$91.9K ﹤0.01% 4282
2013
Q4 		$92K Sell
12,257
-234,985
-95% -$1.61M ﹤0.01% 4479
2013
Q3 		$1.21M Buy
247,242
+42,191
+21% +$240K ﹤0.01% 2794
2013
Q2 		$1.39M Buy
+205,051
New +$1.52M ﹤0.01% 2540

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Credit Suisse's BIOA Position: Q1 2016 in Review

Credit Suisse sold out of BioAmber Inc. (BIOA) in Q1 2016, closing a stake of 19,849 shares — an estimated $123K sold.

Credit Suisse first reported a position in BIOA in Q2 2013 and held it in 11 quarters. The position peaked at $1.39M in Q2 2013. 31 funds tracked by Wall St. Rank hold BIOA as of Q1 2016.

  • Credit Suisse reported no remaining BioAmber Inc. position as of Q1 2016 after selling out during the quarter.
  • Credit Suisse sold 19,849 BioAmber Inc. shares in Q1 2016, an estimated $123K.
  • Credit Suisse first reported a position in BioAmber Inc. in Q2 2013 and held it in 11 quarters.
  • Credit Suisse's BioAmber Inc. position peaked at $1.39M in Q2 2013.
  • 31 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2016.

Based on Credit Suisse's 13F filing for Q1 2016, filed 16 May 2016.